FNY Investment Advisers’s Connect Biopharma Holdings CNTB Stock Holding History

FNY Investment Advisers’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5K	Hold	5,000	–	–	﹤0.01%	624
2026 Q2	$11K	Hold	5,000	–	–	﹤0.01%	601
2026 Q1	$13K	Buy	+5,000	New	+$13K	0.01%	518

Other funds holding CNTB

KWM

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

FNY Investment Advisers's CNTB Position: Q3 2026 in Review

FNY Investment Advisers held its Connect Biopharma Holdings (CNTB) position steady in Q3 2026 at 5,000 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #624.

FNY Investment Advisers first reported a position in CNTB in Q1 2026 and has held it in 3 quarters since. The position peaked at $13K in Q1 2026. 4 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

FNY Investment Advisers held 5,000 shares of Connect Biopharma Holdings worth $5K as of Q3 2026.
FNY Investment Advisers left its Connect Biopharma Holdings share count unchanged in Q3 2026.
Connect Biopharma Holdings made up ﹤0.01% of FNY Investment Advisers's portfolio in Q3 2026, its #624 holding.
FNY Investment Advisers first reported a position in Connect Biopharma Holdings in Q1 2026 and has held it in 3 quarters since.
FNY Investment Advisers's Connect Biopharma Holdings position peaked at $13K in Q1 2026.
4 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on FNY Investment Advisers's 13F filing for Q3 2026, filed 16 Oct 2026.